Re: [india-drug] Medicine prices of few generics to decrease(4)

["CB Tharani" <drcbtharani@yahoo.com>]

Medicine prices of few generics to decrease(4)
**********************************************

Thank you Dr. Kotwani for the mail clarifying some points regarding generic medicines.

Dr. C.B.Tharani
**please add profession and affiliation**
CB Tharani <drcbtharani@yahoo.com>


anita kotwani <anitakotwani@msn.com> wrote: Medicine prices of few generics to decrease(3)
**********************************************   

Dear all,

In relation to the discussion on "Medicine prices of few generics to
decrease", I would like to add the following :

Once the patent protection is over on the original branded drug, other
manufacturers  can  produce the same molecule either under the generic
(international  non-proprietary)  name  or  under brand names of their
own. So all such drugs manufactured either by generic or with a name
are  termed as 'generic equivalents'. In real term branded medicine is
the  medicine  manufactured  by the company who has innovated and      manufactured the medicine for the first time  and  has patent for it, this is called as Innovator Brand, e.g.,for  diclofenac  sodium, Voveran is the innovator brand and diclofenac manufactured by all other companies are generics.

In  India we have mainly generic market as we did not have the typical
patent  law  till recently. So in India for almost all medicines we do
not  have  "brand  premium"  and generally the innovator brand and the
most popular generic is available at the same price.

So  if  the government cap the margins of wholesaler and retailers for medicines  that  are  off  patented,  there  would  be  many medicines
manufactured  by  different  brand names that should be available at a much
lower  rate.  One  example  sited  was  for cetrizine, other medicines
mentioned  in the newspaper were omeprazole, nimesulide. This would be
applicable to all the medicines that are off patent.

    Dr. Anita Kotwani
Department of Pharmacology
V.P.Chest Institute
University of Delhi
Delhi
"anita kotwani" 

       ______________________________________________________________
_______________________________________________
Post message: india-drug@healthnet.org
Subscribe: india-drug-join@healthnet.org
Unsubscribe: india-drug-leave@healthnet.org
Help: india-drug-owner@healthnet.org
Info & archives: http://list.healthnet.org/mailman/listinfo/india-drug



With Regards,

Dr.C.B.Tharani,
Director and Professor,
Institute of Pharmacology,
Madras Medical College,
Chennai-600003.
 		
---------------------------------
Do you Yahoo!?
 Everyone is raving about the  all-new Yahoo! Mail.